{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:11Z","timestamp":1790266871002,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canceropole Nord-Ouest"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:sup>18<\/jats:sup>F-FDG PET\/CT is a standard for many B cell malignancies, while blood DNA measurements are emerging tools. Our objective was to evaluate the correlations between baseline PET parameters and circulating DNA in diffuse large B cell lymphoma (DLBCL) and classical Hodgkin lymphoma (cHL).\n<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Twenty-seven DLBCL and forty-eight cHL were prospectively included. Twelve PET parameters were analysed. Spearman\u2019s correlations were used to compare PET parameters each other and to circulating cell-free DNA ([cfDNA]) and circulating tumour DNA ([ctDNA]). <jats:italic>p <\/jats:italic>values were controlled by Benjamini\u2013Hochberg correction.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among the PET parameters, three different clusters for tumour burden, fragmentation\/massiveness and dispersion parameters were observed. Some PET parameters were significantly correlated with blood DNA parameters, including the total metabolic tumour surface\u00a0(TMTS) describing the tumour\u2013host interface (e.g. <jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.81 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for [ctDNA] of DLBLC), the tumour median distance between the periphery and the centroid (medPCD)\u00a0describing the tumour\u2019s massiveness (e.g. <jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.81 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for [ctDNA] of DLBLC) and the volume of the bounding box including tumours (TumBB)\u00a0describing the disease\u2019s dispersion (e.g. <jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.83 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for [ctDNA] of DLBLC).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Some PET parameters describing tumour burden, fragmentation\/massiveness and dispersion are significantly correlated with circulating DNA parameters of DLBCL and cHL patients. These results could help to understand the pathophysiology of B cell malignancies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-020-00717-y","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T17:02:43Z","timestamp":1602090163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-9910","authenticated-orcid":false,"given":"Pierre","family":"Decazes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bohers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Julien","family":"Viailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruminy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Viennot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Hapdey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"Suppl 5","key":"717_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):116\u201325.","journal-title":"Ann Oncol."},{"key":"717_CR2","unstructured":"Non-Hodgkin lymphoma\u2014cancer stat facts. SEER. [cited 2019 Aug 31]. https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html."},{"key":"717_CR3","unstructured":"Hodgkin lymphoma\u2014cancer stat facts. SEER. [cited 2019 Aug 31]. https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html."},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"e0210224","DOI":"10.1371\/journal.pone.0210224","volume":"14","author":"B Guo","year":"2019","unstructured":"Guo B, Tan X, Ke Q, Cen H. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: a meta-analysis. PLoS ONE. 2019;14:e0210224.","journal-title":"PLoS ONE"},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.","journal-title":"Nat Commun"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"13","key":"717_CR8","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1007\/s00259-019-04420-6","volume":"46","author":"ME Mayerhoefer","year":"2019","unstructured":"Mayerhoefer ME, Riedl CC, Kumar A, Gibbs P, Weber M, Tal I, et al. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma. Eur J Nucl Med Mol Imaging. 2019;46(13):2760\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"717_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/cancers11091282","volume":"11","author":"C Bailly","year":"2019","unstructured":"Bailly C, Bodet-Milin C, Bourgeois M, Gouard S, Ansquer C, Barbaud M, et al. Exploring tumor heterogeneity using PET imaging: the big picture. Cancers (Basel). 2019;11(9):1282.","journal-title":"Cancers (Basel)"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2967\/jnumed.116.181859","volume":"58","author":"F Orlhac","year":"2017","unstructured":"Orlhac F, Nioche C, Soussan M, Buvat I. Understanding changes in tumor texture indices in PET: a comparison between visual assessment and index values in simulated and patient data. J Nucl Med. 2017;58:387\u201392.","journal-title":"J Nucl Med"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1002\/mp.12349","volume":"44","author":"F Ben Bouall\u00e8gue","year":"2017","unstructured":"Ben Bouall\u00e8gue F, Tabaa YA, Kafrouni M, Cartron G, Vauchot F, Mariano-Goulart D. Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas. Med Phys. 2017;44:4608\u201319.","journal-title":"Med Phys"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s00259-018-4041-0","volume":"45","author":"P Decazes","year":"2018","unstructured":"Decazes P, Becker S, Toledano MN, Vera P, Desbordes P, Jardin F, et al. Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET\/CT is an independent prognostic factor of diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2018;45:1672\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"717_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0009-8981(01)00666-0","volume":"313","author":"P Anker","year":"2001","unstructured":"Anker P, Lyautey J, Lederrey C, Stroun M. Circulating nucleic acids in plasma or serum. Clin Chim Acta. 2001;313:143\u20136.","journal-title":"Clin Chim Acta"},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","volume":"36","author":"DM Kurtz","year":"2018","unstructured":"Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, et al. Circulating tumor DNA measurements as early outcome predictors in diffuse large B-Cell lymphoma. J Clin Oncol. 2018;36:2845\u201353.","journal-title":"J Clin Oncol"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","volume":"8","author":"E Bohers","year":"2018","unstructured":"Bohers E, Viailly P-J, Becker S, Marchand V, Ruminy P, Maingonnat C, et al. Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort. Blood Cancer J. 2018;8:74.","journal-title":"Blood Cancer J"},{"key":"717_CR16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.237719","author":"V Camus","year":"2020","unstructured":"Camus V, Viennot M, Lequesne J, Viailly PJ, Bohers E, Bessi L, et al. Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. Haematologica. 2020. https:\/\/doi.org\/10.3324\/haematol.2019.237719.","journal-title":"Haematologica."},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2967\/jnumed.117.199935","volume":"59","author":"F Orlhac","year":"2018","unstructured":"Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L, et al. A postreconstruction harmonization method for multicenter radiomic studies in PET. J Nucl Med. 2018;59:1321\u20138.","journal-title":"J Nucl Med"},{"key":"717_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1148\/radiol.2019182023","volume":"291","author":"F Orlhac","year":"2019","unstructured":"Orlhac F, Frouin F, Nioche C, Ayache N, Buvat I. Validation of a method to compensate multicenter effects affecting CT radiomics. Radiology. 2019;291:53\u20139.","journal-title":"Radiology"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"e0124165","DOI":"10.1371\/journal.pone.0124165","volume":"10","author":"A Chalkidou","year":"2015","unstructured":"Chalkidou A, O\u2019Doherty MJ, Marsden PK. False discovery rates in PET and CT studies with texture features: a systematic review. PLoS ONE. 2015;10:e0124165.","journal-title":"PLoS ONE"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.119.229450","volume":"1","author":"A-S Cottereau","year":"2020","unstructured":"Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O et al. 18F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome. J Nucl Med. 2020;1:40\u20135.","journal-title":"J Nucl Med."},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11899-009-0026-1","volume":"4","author":"N Rachinel","year":"2009","unstructured":"Rachinel N, Salles G. The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate. Curr Hematol Malig Rep. 2009;4:196\u2013201.","journal-title":"Curr Hematol Malig Rep"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/mp.13422","volume":"46","author":"D Vuong","year":"2019","unstructured":"Vuong D, Tanadini-Lang S, Huellner MW, Veit-Haibach P, Unkelbach J, Andratschke N, et al. Interchangeability of radiomic features between [18F]-FDG PET\/CT and [18F]-FDG PET\/MR. Med Phys. 2019;46:1677\u201385.","journal-title":"Med Phys"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"2","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;2:328\u201338.","journal-title":"Radiology."},{"key":"717_CR24","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1007\/s00330-020-06815-8","volume":"30","author":"N Aide","year":"2020","unstructured":"Aide N, Fruchart C, Nganoa C, Gac A-C, Lasnon C. Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. Eur Radiol. 2020;30:4623\u201332.","journal-title":"Eur Radiol"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.119.229724","volume":"61","author":"E Pfaehler","year":"2020","unstructured":"Pfaehler E, van Sluis J, Merema BBJ, van Ooijen P, Berendsen RCM, van Velden FHP, et al. Experimental multicenter and multivendor evaluation of the performance of PET radiomic features using 3-dimensionally printed phantom inserts. J Nucl Med. 2020;61:469\u201376.","journal-title":"J Nucl Med"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s11548-019-02049-2","volume":"14","author":"H Hu","year":"2019","unstructured":"Hu H, Decazes P, Vera P, Li H, Ruan S. Detection and segmentation of lymphomas in 3D PET images via clustering with entropy-based optimization strategy. Int J Comput Assist Radiol Surg. 2019;14:1715\u201324.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"717_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1148\/radiol.2019191114","volume":"294","author":"L Sibille","year":"2020","unstructured":"Sibille L, Seifert R, Avramovic N, Vehren T, Spottiswoode B, Zuehlsdorff S, et al. 18F-FDG PET\/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks. Radiology. 2020;294:445\u201352.","journal-title":"Radiology"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","volume":"8","author":"F Scherer","year":"2016","unstructured":"Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AFM, Esfahani MS, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 2016;8:364ra155.","journal-title":"Sci Transl Med"},{"key":"717_CR29","unstructured":"di Adroterapia Oncologica CN. Plastimatch 1.6\u2014current capabilities and future directions. In: Image-guidance and multimodal dose planning in radiation therapy, p. 108."},{"key":"717_CR30","volume-title":"Image analysis and mathematical morphology","author":"J Serra","year":"1983","unstructured":"Serra J. Image analysis and mathematical morphology. USA: Academic Press, Inc.; 1983."},{"key":"717_CR31","unstructured":"R Development Core Team. R: a language and environment for statistical computing."}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-020-00717-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T01:20:09Z","timestamp":1633569609000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-00717-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-00717-y","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}